Related references
Note: Only part of the references are listed.A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
Eiichiro Suzuki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)
Chigusa Morizane et al.
CANCER SCIENCE (2013)
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
Thomas Walter et al.
EUROPEAN JOURNAL OF CANCER (2013)
Current status of chemotherapy for the treatment of advanced biliary tract cancer
Takashi Sasaki et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2013)
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
Jun Ho Yi et al.
EUROPEAN JOURNAL OF CANCER (2012)
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
Takashi Sasaki et al.
INVESTIGATIONAL NEW DRUGS (2012)
Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer
Kyu-Hyoung Lim et al.
ONCOLOGY (2012)
A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
Masashi Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
Sung Yong Oh et al.
INVESTIGATIONAL NEW DRUGS (2011)
Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer
Takashi Sasaki et al.
INVESTIGATIONAL NEW DRUGS (2011)
Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study
Annekathrin Roth et al.
ONKOLOGIE (2011)
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
Takashi Sasaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan
Shuichi Miyakawa et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2009)
Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene
Kumiko Kitajima et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine
Haruki Morimoto et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)
Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas
Bernard Paule et al.
ONCOLOGY (2007)
Gemcitabine and cisplatin combination chemotherapy in intrahepatic cholangiocarcinoma as second-line treatment: Report of four cases
MA Lee et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
Share Paper
